Furthermore, CAR-T cell therapy using HER2/neu-specific CAR-T cells resulted in on-target-off-tumor toxicity, leading to respiratory failure, multi-organ dysfunction, and subsequent death because of antigen recognition on pulmonary tissue (105). The gene discussed is ERBB2; the disease is neoplasm.